Review
Published on 12 Oct 2022
Mechanisms of venetoclax resistance and solutions
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1005659
- 21,532 views
- 52 citations
125 articles related to "Venetoclax"
Articles
Original Research
Published on 29 Jun 2022
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.864430
- 4,770 views
- 8 citations
Mini Review
Published on 21 Mar 2025
The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1549891
- 4,944 views
- 3 citations
Original Research
Published on 02 Apr 2025
Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1549282
- 3,395 views
- 4 citations
Case Report
Published on 18 Sep 2025
Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with schizophrenia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1671529
- 1,684 views
Case Report
Published on 10 Jul 2024
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1390747
- 2,850 views
- 5 citations
Brief Research Report
Published on 26 Jul 2021
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.598319
- 6,415 views
- 21 citations
Mini Review
Published on 15 Sep 2025
Factors affecting response and resistance to venetoclax in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1577908
- 5,720 views
- 2 citations
Case Report
Published on 05 Jul 2021
Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.693670
- 7,666 views
- 21 citations
Brief Research Report
Published on 20 Mar 2023
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1143881
- 4,790 views
- 6 citations
Original Research
Published on 22 Feb 2022
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.833714
- 5,308 views
- 7 citations
Perspective
Published on 09 Dec 2021
A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2021.797941
- 4,668 views
- 15 citations
Original Research
Published on 06 Jan 2022
Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.777587
- 5,494 views
- 18 citations
Original Research
Published on 21 Dec 2022
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1052060
- 10,096 views
- 7 citations
Case Report
Published on 28 Sep 2022
The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.912696
- 4,360 views
- 6 citations
Review
Published on 05 Nov 2020
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2020.584974
- 23,533 views
- 77 citations